M

MiNA Therapeutics

0 followers

Harnessing an innate mechanism of gene activation, MiNA Therapeutics'​ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.

Industries

Employees

11-50

Links


Org chart

Profile photo

Robert Habib Mba

Collapse
Robin Wright's profile picture
Robin Wright
Group Chief Financial Officer
Peter Bains' profile picture
Peter Bains
Chief Business Officer
Bríd Ryan's profile picture
Bríd Ryan
SVP, Research

Board & advisors

Gur Roshwalb
Non Executive Director
Robert C. Kopple
Non Executive Director
Antonin de Fougerolles
Scientific Advisor
Hans Huber
Scientific Advisor
Pål Sætrom
Co-Founder & Scientific Advisor
John Rossi
Co-Founder & Scientific Advisor
Declan Doogan
Scientific Advisor
Deya Corzo
Scientific Advisor
Nagy Habib
Scientific Advisor

Offices